{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-033049","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2023-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.881211+00:00","generated_at":"2026-06-07T21:17:13.034097+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Integrated BioPharma holds 2023 annual meeting; elects Class II directors, approves advisory pay vote, ratifies auditor","bullets":["Christina Kay, Robert Canarick, and William H. Milmoe elected as Class II directors to serve until 2026.","Non-binding advisory vote on executive compensation approved: 19,964,583 for, 2,510,524 against, 1,715 abstain.","Ratification of Marcum LLP as independent auditor for FY ending June 30, 2024 passed: 23,762,534 for, 7,281 against.","Vote results: Kay 20,393,822 for; Canarick 22,301,725 for; Milmoe 22,285,400 for."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-033049","json":"https://secwatch.observer/filing/0001437749-23-033049.json","markdown":"https://secwatch.observer/filing/0001437749-23-033049.md","text":"https://secwatch.observer/filing/0001437749-23-033049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/inbp20231127_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:17:13.034097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"383c206cd267cd85ae6d9d06e81b936b16863fa6","claim":"INTEGRATED BIOPHARMA INC shareholders approved Election of Class II directors for a three-year term at the 2023-11-27 meeting.","evidence_excerpt":"Christina Kay 20,393,822 2,083,000 1,292,993 Robert Canarick 22,301,725 175,097 1,292,993 William H Milmoe 22,285,400 191,422 1,292,993","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-27"}],"fact_type":"shareholder_vote"},{"claim_id":"4a18d165eae9c4c1b327c8ff19f9f009e8910b57","claim":"INTEGRATED BIOPHARMA INC shareholders approved Ratify the appointment of Marcum LLP as the Company’s independent auditors for fiscal year ending June 30, 2024 at the 2023-11-27 meeting.","evidence_excerpt":"For Against Abstain 23,762,534 7,281 -","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-27"}],"fact_type":"shareholder_vote"},{"claim_id":"cfb2d61f63ff0b6f696e19d94f89d534bf114128","claim":"INTEGRATED BIOPHARMA INC shareholders approved Non-binding, Advisory Vote on Executive Compensation at the 2023-11-27 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 19,964,583 2,510,524 1,715 1,292,993","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923033049/0001437749-23-033049-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-27"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}